Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S156000
Reexamination Certificate
active
06858625
ABSTRACT:
This invention relates to 1-(6-amino-3,5-difluoropyridin-2-yl)-8-bromo-7-(3-ethylaminoazetidin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a salt thereof, and also to a medicine containing the same. This compound has characteristic features that, when administered orally, it has extremely high blood half-life and bioavailability while retaining properties that it has extremely high antimicrobial effects and has low toxicity. It can be used widely as preventives, therapeutics and the like for various infectious diseases of human and animals.
REFERENCES:
patent: 5998436 (1999-12-01), Yazaki et al.
patent: 0 388 298 (1990-09-01), None
patent: 0 897 919 (1999-02-01), None
patent: 0 911 327 (1999-04-01), None
patent: 0 945 435 (1999-09-01), None
patent: 11-292873 (1999-10-01), None
patent: WO 9505373 (1995-02-01), None
patent: 9711068 (1997-03-01), None
Amano Hirotaka
Hayashi Norihiro
Hirao Yuzo
Kuramoto Yasuhiro
Niino Yoshiko
Morris Patricia L.
Wakunaga Pharmaceutical Co., Ltd.
LandOfFree
Quinolinecarboxylic acid derivative or salts thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolinecarboxylic acid derivative or salts thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinecarboxylic acid derivative or salts thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3513216